微信公众号:蹊之美股生物医药
/AlleyMazeResearch
主要公司:Nkarta (NASDAQ: NKTX)
投资要点
NKX101的靶点NKG2D,治疗血液系统恶性肿瘤和实体瘤,这个靶点为NK细胞完成天然免疫的主要作用方式,临床上第一个患者已经用药。和CD16靶点有所不同,CD16是通过mA...查看全文
美股滚雪球2020-11-02 17:02
$赛诺菲-安万特(SNY)$ 以3.08亿欧元收购Kiadis,后者是做Off-the-shelf NK cell therapies ,利好$Fate Therapeutics(FATE)$ $Nkarta(NKTX)$ $NantKwest(NK)查看全文
神圣的升值毁灭者2020-10-10 11:31
$Nkarta(NKTX)$ Q2 EPS of -$30.06 may not be comparable to consensus of -$4.18.。
RA Capital 披露 了其在Nkarta的17.2%股权查看全文
绿专资本集团2020-07-08 10:11
近日全球资本市场一片红火,各大市场均大涨,亚太资本市场强劲,欧洲股市表现良好,美股凭借良好基本面,道指收涨1.78%,标普500指数涨1.59%,纳指涨2.53%。
在火热行情的带动下,IPO市场已愈加活跃,本周美股迎来5只新股,其中2家来自中企:蓝城兄弟、趣活科技。
蓝城兄弟
上市时...查看全文
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-084588 Size: 4 KB 网页链接
$Nkarta(NKTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005460 Act: 33 Size: 4 KB 网页链接
$Nkarta(NKTX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000950170-24-083761 Act: 34 Size: 231 KB 网页链接
$Nkarta(NKTX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0000950170-24-078152 Act: 34 Size: 233 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075733 Size: 5 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075723 Size: 5 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075730 Size: 5 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075728 Size: 5 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075732 Size: 5 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073729 Size: 33 KB 网页链接